Melatonin prevents methotrexate‐induced hepatorenal oxidative injury in rats

Abstract:  Regarding the mechanisms of methotrexate (MTX) hepatotoxicity and nephrotoxicity, several hypotheses have been put forward, among which oxidative stress (including depletion of glutathione) is likely. This investigation elucidates the role of free radicals in MTX‐induced toxicity and the protection by melatonin. Wistar albino rats were injected with MTX intraperitoneally. Following a single dose of MTX (20 mg/kg), either saline (MTX group) or melatonin (10 mg/kg, MTX + Mel group) was administered for 5 days. In other rats, physiologic saline (control group) or melatonin (10 mg/kg, Mel group) was injected for 5  days, following a single injection of saline. On the sixth day, rats were killed to obtain blood, liver, and kidney tissue samples. Malondialdehyde (MDA), an end product of lipid peroxidation, and glutathione (GSH), a key antioxidant, levels were evaluated in blood and tissue homogenates. Reactive oxygen metabolite‐induced inflammatory changes in kidney and liver tissues were evaluated by measuring myeloperoxidase (MPO) activity, an index of neutrophil infiltration. MTX administration resulted in increased MDA levels and MPO activity and decreased GSH levels in the blood, liver, and kidney whereas melatonin reversed these effects. When melatonin was administered alone, no significant changes in biochemical parameters were noted. In conclusion, the present study suggests that melatonin may be of therapeutic benefit when used with MTX.

[1]  A. Kourounakis,et al.  Antioxidant Activity of Guaiazulene and Protection Against Paracetamol Hepatotoxicity in Rats , 1997, The Journal of pharmacy and pharmacology.

[2]  E. Hersh,et al.  Hepatotoxic effects of methotrexate , 1966, Cancer.

[3]  J. Kremer,et al.  Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates. , 1986, Arthritis and rheumatism.

[4]  E. Mazzon,et al.  Beneficial effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion , 2000, Journal of pineal research.

[5]  T. Ozawa,et al.  Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: disturbances in glutathione peroxidase activity. , 1989, Biochemical and biophysical research communications.

[6]  Vijayalaxmi,et al.  Melatonin and protection from genetic damage in blood and bone marrow: Whole‐body irradiation studies in mice , 1999, Journal of pineal research.

[7]  A. Wakatsuki,et al.  Melatonin protects against age‐related DNA damage in the brains of female senescence‐accelerated mice , 1999, Journal of pineal research.

[8]  A. Campello,et al.  Effect of methotrexate (MTX) on NAD(P)+ dehydrogenases of HeLa cells: malic enzyme, 2‐oxoglutarate and isocitrate dehydrogenases , 1997, Cell biochemistry and function.

[9]  D. Granger,et al.  Ischemia‐reperfusion injury: A radical view , 1988, Hepatology.

[10]  R. Reiter,et al.  Melatonin: reducing the toxicity and increasing the efficacy of drugs , 2002, The Journal of pharmacy and pharmacology.

[11]  R. Schilsky,et al.  Clinical pharmacology of methotrexate. , 1981, Cancer treatment reports.

[12]  G. Curt,et al.  The pharmacology and clinical use of methotrexate. , 1983, The New England journal of medicine.

[13]  J. Epstein,et al.  Glutamine Enhances Selectivity of Chemotherapy Through Changes in Glutathione Metabolism , 1995, Annals of surgery.

[14]  Sudhir V. Shah,et al.  Oxidant mechanisms in toxic acute renal failure. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  R. Reiter,et al.  Melatonin in relation to the antioxidative defense and immune systems: possible implications for cell and organ transplantation , 1999, Journal of Molecular Medicine.

[16]  R. Reiter,et al.  Lipopolysaccharide-induced hepatotoxicity is inhibited by the antioxidant melatonin. , 1995, European journal of pharmacology.

[17]  H. M. Palmer.  Hepatotoxicity of methotrexate in the treatment of psoriasis. , 1973, The Practitioner.

[18]  R. Reiter,et al.  Physiological levels of melatonin contribute to the antioxidant capacity of human serum , 1999, Journal of pineal research.

[19]  I. Goldman.  Analysis of the cytotoxic determinants for methotrexate (NSC 740): a role for 'free' intracellular drug , 1975 .

[20]  R. Reiter,et al.  Actions of Melatonin in the Reduction of Oxidative Stress , 2000, Journal of Biomedical Science.

[21]  M. Tsurusawa,et al.  Differential induction of apoptosis on human lymphoblastic leukemia Nalm-6 and Molt-4 cells by various antitumor drugs. , 1997, International journal of hematology.

[22]  R. Auerbach,et al.  Hepatotoxicity of long-term methotrexate therapy for psoriasis. , 1973, Archives of internal medicine.

[23]  E. Beutler.  Glutathione in red blood cell metabolism , 1975 .

[24]  R. Reiter,et al.  Melatonin reduces rat hepatic macromolecular damage due to oxidative stress caused by delta-aminolevulinic acid. , 2000, Biochimica et biophysica acta.

[25]  S. Aust,et al.  Microsomal lipid peroxidation. , 1978, Methods in enzymology.

[26]  P. Kintzel.  Anticancer Drug—Induced Kidney Disorders , 2001, Drug safety.

[27]  J. Bertino,et al.  Methotrexate Accumulation and Folate Depletion in Cells as a Possible Mechanism of Chronic Toxicity to the Drug , 1981, British journal of haematology.

[28]  M. Balińska,et al.  Regulation of methotrexate polyglutamate accumulation in vitro: effects of cellular folate content. , 1983, Biochemical pharmacology.

[29]  R. Reiter,et al.  Melatonin, mitochondria, and cellular bioenergetics , 2001, Journal of pineal research.

[30]  J. Linden,et al.  The role of inflammation in vascular diseases , 2000, Journal of leukocyte biology.

[31]  E. El-Bassiouni,et al.  Antioxidants as Adjuvant Therapy in Rheumatoid Disease , 2001, Arzneimittelforschung.

[32]  J. Hokanson,et al.  Amelioration of cis-platinum nephrotoxicity by orgotein (superoxide dismutase). , 1978, Physiological chemistry and physics.

[33]  A. Campello,et al.  Methotrexate: pentose cycle and oxidative stress , 1998, Cell biochemistry and function.

[34]  E. Przybytkowski,et al.  Correlation between glutathione and stimulation of the pentose phosphate cycle in situ in Chinese hamster ovary cells exposed to hydrogen peroxide. , 1996, Archives of biochemistry and biophysics.

[35]  R. Reiter,et al.  Melatonin reduces kainate‐induced lipid peroxidation in homogenates of different brain regions , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  M. Zhang,et al.  Protection effects of procaine on oxidative stress and toxicities of renal cortical slices from rats caused by cisplatin in vitro , 2005, Archives of Toxicology.

[37]  G. Şener,et al.  Melatonin protects against gentamicin‐induced nephrotoxicity in rats , 2002, Journal of pineal research.

[38]  D. Acuña-Castroviejo,et al.  Free Radical‐Mediated Molecular Damage , 2001, Annals of the New York Academy of Sciences.

[39]  B. Poeggeler,et al.  Melatonin reduces H2O2‐induced lipid peroxidation in homogenates of different rat brain regions , 1995, Journal of pineal research.

[40]  Willem Boogerd,et al.  Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure , 2001, Cancer Chemotherapy and Pharmacology.

[41]  M. Heenen,et al.  Methotrexate induces apoptotic cell death in human keratinocytes , 1998, Archives of Dermatological Research.

[42]  J. Chládek,et al.  An in vitro study on methotrexate hydroxylation in rat and human liver. , 1997, Physiological research.

[43]  R. Cameron,et al.  Inducers of cytochrome P450 2E1 enhance methotrexate-induced hepatocytoxicity. , 1999, Clinical biochemistry.

[44]  F. Sultana,et al.  Folinic acid protects against suppression of growth by methotrexate in mice. , 2001, Biopharmaceutics & drug disposition.

[45]  G. Kajiyama,et al.  Acetaminophen-induced hepatic injury in mice: the role of lipid peroxidation and effects of pretreatment with coenzyme Q10 and alpha-tocopherol. , 1995, Free radical biology & medicine.

[46]  C. S. Shyamala Devi,et al.  Vitamin E protects intestinal basolateral membrane from CMF-induced damages in rat. , 1995, Indian journal of physiology and pharmacology.

[47]  P. Hall,et al.  Hepatotoxicity in a rat model caused by orally administered methotrexate , 1991, Hepatology.

[48]  D. Ross.  Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free-radical induced toxicity and glutathione-dependent protection. , 1988, Pharmacology & therapeutics.

[49]  B. Brodie,et al.  Drug metabolism as a cause of drug toxicity. , 1973, Drug metabolism and disposition: the biological fate of chemicals.

[50]  Eiichi Goto,et al.  Methotrexate Poisoning with Acute Hepatorenal Dysfunction , 2001, Journal of toxicology. Clinical toxicology.

[51]  J. Mørland,et al.  Isolated rat hepatocytes in suspension: Potential hepatotoxic effects of six different drugs , 1984, Archives of Toxicology.

[52]  D E Griswold,et al.  Assessment of myeloperoxidase activity in whole rat kidney. , 1990, Journal of pharmacological methods.

[53]  M. Schiff,et al.  Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis. , 2000, Seminars in arthritis and rheumatism.